首页> 外国专利> Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders

Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders

机译:用于确定罹患2型糖尿病和其他胰岛素抵抗相关疾病的风险的方法和计算机程序产品

摘要

Methods for assessing the risk of developing Type 2 diabetes and other related disorders include obtaining an NMR derived reference spectrum for a known glucose concentration sample and storing this information as a reference standard. A patient blood sample is collected and NMR derived patient spectrums for the blood sample are obtained. The two NMR data sets (the reference and the patient) are compared and a glucose concentration is determined for the patient sample. The glucose concentration can be evaluated with a blood sample undergoing lipoprotein cholesterol evaluation. The NMR based test can be used to concurrently provide a glucose concentration and lipoprotein constituent values based on a single testing event. The disclosure also includes a multi-purpose test, i.e., a test which concurrently provides lipoprotein screening and coronary heart disease risk evaluation along with a diabetes screening and risk assessment for developing Type 2 diabetes. A method for assessing diabetes includes identifying the presence of diabetic dyslipidemia based on the values of predetermined NMR measured lipoprotein constituents.
机译:评估罹患2型糖尿病和其他相关疾病的风险的方法包括获得已知葡萄糖浓度样品的NMR衍生参考光谱,并将此信息存储为参考标准。收集患者血液样本,并获得该血液样本的NMR衍生患者光谱。比较两个NMR数据集(参考和患者),并确定患者样品的葡萄糖浓度。可以用进行脂蛋白胆固醇评估的血液样品评估葡萄糖浓度。基于NMR的测试可用于基于单个测试事件同时提供葡萄糖浓度和脂蛋白成分值。本公开还包括一种多功能测试,即同时提供脂蛋白筛查和冠心病风险评估以及针对发展为2型糖尿病的糖尿病筛查和风险评估的测试。一种评估糖尿病的方法,包括基于预定的NMR测得的脂蛋白成分的值鉴定糖尿病性血脂异常的存在。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号